terbutaline has been researched along with Premature Birth in 12 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Evidence of low strength from observational studies with risk of bias favored SQ terbutaline pump for the outcomes of delivery at <32 and <37 weeks, mean days of pregnancy prolongation, and neonatal death." | 8.88 | Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis. ( Ansari, MT; Gaudet, LM; Singh, K; Skidmore, B; Tsertsvadze, A; Weeks, L, 2012) |
| " We found no strong evidence that terbutaline maintenance therapy offered any advantages over saline placebo or oral terbutaline maintenance therapy in reducing adverse neonatal outcomes by prolonging pregnancy among women with arrested preterm labour." | 4.90 | Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes. ( Chawanpaiboon, S; Dowswell, T; Laopaiboon, M; Lumbiganon, P; Sangkomkamhang, US, 2014) |
| " No differences in the incidence of preterm birth or perinatal mortality were seen when magnesium maintenance therapy was compared with placebo or no treatment; or alternative therapies (ritodrine or terbutaline)." | 4.89 | Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. ( Crowther, CA; Han, S; Moore, V, 2013) |
| " Evidence of low strength from observational studies with risk of bias favored SQ terbutaline pump for the outcomes of delivery at <32 and <37 weeks, mean days of pregnancy prolongation, and neonatal death." | 4.88 | Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis. ( Ansari, MT; Gaudet, LM; Singh, K; Skidmore, B; Tsertsvadze, A; Weeks, L, 2012) |
| " No differences in the incidence of preterm birth or perinatal mortality were seen when magnesium maintenance therapy was compared with placebo or no treatment; or alternative therapies (ritodrine or terbutaline)." | 4.86 | Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. ( Crowther, CA; Han, S; Moore, V, 2010) |
| " Human myometrial strips from cesarean sections at full-term pregnancy and at preterm labor were stimulated with oxytocin, and the inhibitory effects of theophylline, rolipram and terbutaline were studied." | 3.79 | Uterus-relaxing effect of β2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in vivo and on pregnant human myometrium in vitro. ( Ducza, E; Falkay, G; Gáspár, R; Hajagos-Tóth, J; Klukovits, A; Kormányos, Z; Seres, AB; Verli, J, 2013) |
| " Our aim was to study the effects of the non-selective phosphodiesterase (PDE) inhibitor theophylline and the selective PDE4 inhibitor rolipram on the uteri of intact late-pregnant female rats (on days 20 and 22 of pregnancy) and of pregnant rats treated with lipopolysaccharide (LPS) to evoke preterm labor (on day 20)." | 3.76 | Improving the relaxing effect of terbutaline with phosphodiesterase inhibitors: studies on pregnant rat uteri in vitro. ( Falkay, G; Gáspár, R; Klukovits, A; Verli, J, 2010) |
| "Preterm birth is a major contributor to perinatal mortality and morbidity worldwide." | 2.50 | Betamimetics for inhibiting preterm labour. ( Dowswell, T; Neilson, JP; West, HM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Buckley, VA | 1 |
| Wu, J | 1 |
| De Vries, B | 1 |
| Han, S | 2 |
| Crowther, CA | 2 |
| Moore, V | 2 |
| Neilson, JP | 1 |
| West, HM | 1 |
| Dowswell, T | 2 |
| Chawanpaiboon, S | 1 |
| Laopaiboon, M | 1 |
| Lumbiganon, P | 3 |
| Sangkomkamhang, US | 1 |
| Yamasmit, W | 2 |
| Chaithongwongwatthana, S | 2 |
| Tolosa, JE | 2 |
| Limpongsanurak, S | 2 |
| Pereira, L | 2 |
| Klukovits, A | 3 |
| Márki, A | 1 |
| Páldy, E | 1 |
| Benyhe, S | 1 |
| Gálik, M | 1 |
| Falkay, G | 3 |
| Gáspár, R | 3 |
| Rebarber, A | 1 |
| Cleary-Goldman, J | 1 |
| Istwan, N | 1 |
| Rhea, D | 1 |
| Stanziano, G | 1 |
| Saltzman, D | 1 |
| Verli, J | 2 |
| Gaudet, LM | 1 |
| Singh, K | 1 |
| Weeks, L | 1 |
| Skidmore, B | 1 |
| Tsertsvadze, A | 1 |
| Ansari, MT | 1 |
| Kormányos, Z | 1 |
| Hajagos-Tóth, J | 1 |
| Ducza, E | 1 |
| Seres, AB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acute Tocolysis With Terbutaline vs Placebo Prior to Emergency Caesarean Delivery for Suspected Intrauterine Fetal Compromise[NCT05326269] | 100 participants (Actual) | Interventional | 2017-04-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for terbutaline and Premature Birth
| Article | Year |
|---|---|
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.
Topics: Female; Humans; Magnesium Chloride; Magnesium Compounds; Magnesium Oxide; Magnesium Sulfate; Obstetr | 2013 |
Betamimetics for inhibiting preterm labour.
Topics: Adrenergic beta-Agonists; Female; Fenoterol; Hexoprenaline; Humans; Obstetric Labor, Premature; Preg | 2014 |
Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes.
Topics: Female; Gestational Age; Humans; Maintenance Chemotherapy; Obstetric Labor, Premature; Pregnancy; Pr | 2014 |
Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Female; Fenoterol; Fetal Membranes | 2015 |
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.
Topics: Female; Humans; Magnesium Chloride; Magnesium Compounds; Magnesium Oxide; Magnesium Sulfate; Obstetr | 2010 |
Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis.
Topics: Adult; Birth Weight; Delivery, Obstetric; Female; Gestational Age; Humans; Infant, Newborn; Infusion | 2012 |
Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Female; Fenoterol; Gestational Age | 2012 |
5 other studies available for terbutaline and Premature Birth
| Article | Year |
|---|---|
Outcomes following acute tocolysis prior to emergency caesarean section.
Topics: Adult; Cesarean Section; Emergency Treatment; Female; Humans; Labor, Obstetric; Obstetric Labor, Pre | 2020 |
Inflammatory processes enhance cAMP-mediated uterus relaxation in the pregnant rat: the role of TNF-alpha.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Cyclic AMP; Disease Models, | 2009 |
The association of elective cessation of tocolysis and preterm birth in singleton gestations.
Topics: Adolescent; Adult; Comorbidity; Female; Georgia; Gestational Age; Humans; Infant, Newborn; Marital S | 2009 |
Improving the relaxing effect of terbutaline with phosphodiesterase inhibitors: studies on pregnant rat uteri in vitro.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Cyclic AMP; Drug Synergism; Female; Lipopolysaccharide | 2010 |
Uterus-relaxing effect of β2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in vivo and on pregnant human myometrium in vitro.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type | 2013 |